Clinical profile of Laron dwarfism - experience from a tertiary care institute in Chennai

Chidambaram Sethuraman1, Seenivasan Venkatasamy1

  • 1Department of Paediatrics, Institute of Child Health and Hospital for Children, Chennai, Tamil Nadu, India.

Insights

Laron dwarfism, a rare condition causing extreme stunting, presents with low Insulin-like Growth Factor-1 (IGF-1) and high Growth Hormone (GH). Early suspicion is key for children exhibiting Growth Hormone Deficiency (GHD) symptoms.

Area of Science:

  • Pediatrics
  • Genetics
  • Endocrinology

Background:

  • Laron dwarfism is a rare genetic disorder.
  • Approximately 350 cases reported globally.
  • First identified in Israeli Jewish children.

Purpose of the Study:

  • Describe the clinical profile of nine children with Laron dwarfism.
  • Analyze cases from the Institute of Child Health, Chennai.

Main Methods:

  • Retrospective analysis of case records.
  • Study period: 2010 to 2018.

Main Results:

  • Nine children diagnosed with Laron dwarfism (6 males, 3 females).
  • Mean age at diagnosis: 3 years; mean height Z-score: -7.7.
  • All presented with extreme short stature, low IGF-1, high GH, characteristic facies; microcephaly and micropenis observed in some.

Conclusions:

  • High suspicion of Laron syndrome is warranted in children with features of Growth Hormone Deficiency (GHD) and extreme stunting.
  • Clinical presentation includes specific facial features and biochemical markers.
Abstract